Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth
Senestech (NASDAQ: SNES - Get Free Report) and Omeros (NASDAQ: OMER - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based
SURPRISE, Ariz., Feb. 18, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), a leader in birth control solutions for managing rodent populations, today reported signif
Transition from Third-Party to Internal Management Expected to Increase Revenue and Enhance Margin on E-Commerce Channel Moving Forward While Building on Early Success PHOENIX, Feb. 10, 2026 /PRNewsw
Rockwell Medical (NASDAQ: RMTI - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses

SenesTech's Evolve® Approved in New Zealand

08:00am, Monday, 02'nd Feb 2026
Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions f

SenesTech Announces CEO Transition Plan

04:05pm, Wednesday, 28'th Jan 2026
Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTe
Owens and Minor (NYSE: OMI - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies
SURPRISE, Ariz. , Nov. 11, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the pioneer in fertility control for managing animal pest populations, proudly announces the addition of Sarah Mann an
SenesTech, Inc. ( SNES ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Joel Fruendt - CEO, President & Director Thomas Chesterman - Executive VP, CFO, Treasurer & Secretary
77% Revenue Growth in Evolve® Rodent Birth Control™ Products Strong Cash Balance and Progress Toward Profitability SURPRISE, Ariz. , Nov. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), th
E-Commerce Presence Marks a Gateway to In-Store Opportunities for Evolve™ SURPRISE, Ariz. , Nov. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managi
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX , Nov. 3, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fer
SWAMPSCOTT, Mass. , Oct. 13, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for pest management, today announced the Town of Swampscott has launched a groundbrea
SURPRISE, Ariz. , Sept. 17, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations, today announced that it will participate in a we
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE